Evidence map›Paper›PMID 39428716›Full record

ReviewHistopathology2025

4D pathology: translating dynamic epithelial tubulogenesis to prostate cancer pathology.

Hridya Harikumar, Martin E van Royen, Geert Jlh van Leenders

Abstract readReview
In one paragraph

Review in Histopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. LncRNA expression in prostate cancer: FromNon-coding RNA research · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hridya HarikumarDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands.ORCID https://orcid.org/0009-0009-6269-3002
Martin E van RoyenDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands.ORCID https://orcid.org/0000-0002-6814-0996
Geert Jlh van LeendersDepartment of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands.ORCID https://orcid.org/0000-0003-2176-9102

Funding

Jaap Schouten Foundation
6 · The paper itself

Abstract

The Gleason score is the gold standard for grading of prostate cancer (PCa) and is assessed by assigning specific grades to different microscopical growth patterns. Aside from the Gleason grades, individual growth patterns such as cribriform architecture were recently shown to have independent prognostic value for disease outcome. PCa grading is performed on static tissue samples collected at one point in time, whereas in vivo epithelial tumour structures are dynamically invading, branching and expanding into the surrounding stroma. Due to the lack of models that are able to track human PCa microscopical developments over time, our understanding of underlying tissue dynamics is sparse. We postulate that human PCa expansion utilizes embryonic and developmental tubulogenetic pathways. The aim of this study is to provide a comprehensive overview of developmental pathways of normal epithelial tubule formation, elongation, and branching, and relate those to the static microscopical PCa growth patterns observed in daily clinical practise. This study could provide a rationale for the discerned pathological interobserver variability and the clinical outcome differences between PCa growth patterns.

Indexed as

Prostatic NeoplasmsEpithelial CellsHumansMaleNeoplasm GradingProstatecell polaritycribriformgrowth patternlumen formationprostate cancertubulogenesis

Identifiers

PMID39428716
PMCPMC11903113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.